Jan 05, 2026 5:00am EST ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
Dec 19, 2025 7:00am EST ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories
Nov 26, 2025 8:00am EST Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1
Nov 19, 2025 8:13am EST ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET.
Nov 18, 2025 8:00am EST ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
Oct 29, 2025 8:30am EDT ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology
Oct 22, 2025 7:30am EDT ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
